Mantle cell lymphoma and involvement of lacrimal glands and orbit
E.V. Vilchevskaia, Cand Sc (Med)
E.I. Eshchenko, Cand Sc (Med)
Gusak Institute of Urgent and Reconstructive Surgery, National Medical Science Academy of Ukraine
Kyiv (Ukraine)
Key words: non-Hodgkin’s lymphoma, mantle cell lymphoma, lacrimal gland, orbit, polychemotherapy
1.Hanson KP, Imianitov EN. [Epidemiology and biology of non-Hodgkin’s lymphomas]. Pract Oncol. 2004;5(3):163-8. Russian
2.Tiuliandin SA, Perevodchikova NI, Nosov DA, Translation Editors. [ESMO Minimal Clinical Recommendations]. Moscow: Blokhin Russian Oncological Research Center; 2006. 128 p. Russian
3.Bairey O, Kremer I, Rakowsky E et al. Orbital and adnexal involvement in systemic non–Hodgkin’s lymphoma. Cancer. 1994 May 1;73(9):2395-9.
Crossref   Pubmed
4.Соupland SE. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines]. Ophthalmologe. 2004 Feb;101(2):197-215. German
Crossref   Pubmed
5.Gaidukova SM, editor. [Hematology and blood transfusion science]. Kyiv: Try krapky; 2001. 752 p. Ukrainian
6.Margo CE, Mulla ZD. Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. Ophthalmology. 1998 Jan;105(1):185-90.
Crossref   Pubmed
7.Iurchenko OV, Mikhalat SV, Aleksik EM. [Immunophenotypical prognostic factors for the course of non-Hogkin’s malignant lymphoma]. Ukr J Hemat Blood Transf. 2009;3:14-21. Russian
8.Martina ZV, Kostiukevich OM. [Russian National Conference on Malignant Lymphomas, Moscow, 30-31 October, 2008]. Ukr J Hemat Blood Transf. 2008;8:44-6. Russian
9.Grishina EE, Guzenko ES. [Ocular lymphoma: Clinical course and prognostic features]. Rus Med J. 2013;1:30-3. Russian
10.Golenkov AK, Miterov G.Iu. [Immune phenotype and clinical course of non-Hodgkin’s lymphoma]. J Hemat Blood Transf. 2008;1:41-4. Russian